Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6264 of 6351
-
Healthy donors needed for research sample bank
Knowledge-focused Recruiting nowBackground: Laboratory tests that use blood and urine can provide a great deal of information about human health and disease. To develop even better tests and to improve the ways samples are handled for testing researchers need to experiment with samples from healthy people. Ob…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Diabetes drug cocktail tested in healthy volunteers
Knowledge-focused CompletedThis study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Promising brain tumor treatment study halted before it began
Disease control CancelledThe goal of this clinical trial is to assess the safety, toxicity, and antitumor activity of fourth ventricular infusions of nivolumab plus 5-azacytidine for recurrent ependymoma and nivolumab plus methotrexate for recurrent medulloblastoma and other CNS malignancies. Additional…
Phase 1 • Sponsor: Jeffrey Treiber • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New inhaled drug tested in healthy volunteers – no treatment expected
Knowledge-focused CompletedThe purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of AZD4604 when administered as single or multiple inhaled doses to healthy Japanese and Chinese participants.
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Yale study tests if a pep talk boosts depression drug – but only one person joined
Knowledge-focused Stopped earlyThe investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific eff…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New drug TML-6 tested for safety in healthy adults
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability, single-ascending dose (SAD), multiple-ascending dose (MAD), food effect, and pharmacokinetic (PK) Study of TML-6.
Phase 1 • Sponsor: Merry Life Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Brain stent blood thinner study pulled before it began
Disease control CancelledThis study is a prospective, multicenter, open-label, randomized controlled clinical trial, aims to assess the clinical non-inferiority of 3 months (short-term) vs 6 months (long-term) of Dual Anti-Platelet Therapy (DAPT) in patients after implanted NOVA intracranial sirolimus-el…
Sponsor: Sino Medical Sciences Technology Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Magne-B6 gets a makeover: new tablet tested against old liquid
Knowledge-focused CompletedThe purpose of the study is to assess the relative bioavailability of two Magne-B6 preparations, in fasting conditions.
Phase 1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:53 UTC
-
Healthy volunteers help test new imaging agent
Knowledge-focused CompletedThis is a Phase 1, single-center, open-label, single-arm, dose-escalation positron emission tomography study to assess the safety and tolerability, immunogenicity, Pharmacokinetics, dosimetry, and biodistribution after GEH200521 (18F) Injection is co-administered with GEH200520 I…
Phase 1 • Sponsor: GE Healthcare • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Neck bone volume may reveal growth milestones in teen girls
Knowledge-focused CompletedCorrelation between cervical vertebrae volume with maturational stage through CBCT
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massage meets engineering: tensegrity principle tested on healthy muscles
Knowledge-focused CompletedThe study design is a randomised, controlled, parallel, two-arm trial. The subjects are randomly assigned to one of the study groups: the intervention group or the control group. The study will analyze the applicability of the tensegrity principle in the massage therapy. The main…
Sponsor: Wroclaw University of Health and Sport Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Diabetes drug and exercise study pulled before starting
Knowledge-focused CancelledThe overall aim of this research proposal is to determine the impact of GLP1 agonists on post-exercise arterial stiffness. Therefore, the investigators will examine the cardiovascular responses to exercise in individuals with Type 2 Diabetes mellitus (T2DM) taking these medicatio…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Promising cancer drug trial pulled before it even started
Disease control CancelledTo learn if ASTX727 given alone or in combination with donor lymphocyte infusion (DLI) can help to control certain types of hematological neoplasms (blood-based cancers) after a stem cell transplant.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug UCB9741 tested for safety in healthy people
Knowledge-focused CompletedThe purpose of the study is investigate the safety, tolerability and pharmacokinetic of UCB9741 after 2 dose strengths administered subcutaneous as a single-dose in healthy Caucasian and Japanese participants.
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New oxygen mask put to the test against old version
Knowledge-focused CancelledThe purpose of this study is to determine if the performance of a newly released oxygen mask is the same, better, or worse than previous mask version. We will measure the flow rate necessary to maintain the same oxygen saturation in adult patients using each mask.
Sponsor: Northwestern Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Healthy volunteers help track new Drug's journey through the body
Knowledge-focused CompletedThe purpose of this study is to learn what happens to calderasib in a healthy person's body over time and how it is cleared from the body.
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Tiny MS drug safety study stopped early – no results yet
Disease control Stopped earlyThis is a single-site, single-arm, single-dose, Phase 1 study of the safety of bryostatin in participants with multiple sclerosis (MS) receiving any disease modifying therapy (DMT).
Phase 1 • Sponsor: Robert Fox • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Healthy volunteers test new drug AJ302-IM for safety
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AJ302-IM following intramuscular administration of single ascending doses in healthy volunteers.
Phase 1 • Sponsor: AnnJi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Healthy volunteers test two injection devices for drug delivery
Knowledge-focused CompletedThe purpose of this study is to evaluate the amount of mirikizumab (test) that gets into the blood stream and how long it takes the body to get rid of it, when given via autoinjector, an injection under the skin, compared to mirikizumab (reference) solution given via autoinjector…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New drug AZD5148 passes first safety check in healthy volunteers
Knowledge-focused CompletedThe purpose of this study is to measure safety, tolerability, and pharmacokinetics (PK) of a single dose of AZD5148 administered via intravenous (IV) bolus or intramuscular (IM) injection in healthy participants
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC